Keyphrases
Neuroprotection
100%
Erythropoietin
100%
Brain Magnetic Resonance Imaging
100%
2-year Outcome
100%
Corrected Age
100%
Extremely Preterm Infants
100%
Term Equivalent
100%
Brain Injury
75%
Brain Abnormalities
75%
Neurodevelopmental Outcome
75%
Injury Severity Score
75%
Third Edition
50%
Gestational Age
50%
Placebo Groups
50%
Magnetic Resonance Findings
50%
Bayley Scales of Infant Development
50%
Bronchopulmonary Dysplasia
25%
Retinopathy of Prematurity
25%
Cognitive-motor
25%
Antibiotic Treatment
25%
Opioids
25%
Cognitive Ability
25%
Treatment Assignment
25%
White Matter Injury
25%
Brain MRI
25%
Treatment Group
25%
Intubation
25%
Recruitment Sites
25%
Benzodiazepines
25%
Magnetic Resonance Imaging Scan
25%
Motor Abilities
25%
Cranial Ultrasound
25%
Potential Risk Factors
25%
Generalized Estimating Equations
25%
Language Ability
25%
Global Brain
25%
Erythropoietin Therapy
25%
Intraventricular Hemorrhage
25%
Inpatient Treatment
25%
Placebo Control Groups
25%
Periventricular Leukomalacia
25%
Inpatient Complications
25%
Score Scale
25%
Toddler Development
25%
Medicine and Dentistry
Magnetic Resonance Imaging
100%
Neuroprotection
100%
Erythropoietin
100%
Brain Injury
60%
Placebo
60%
Brain Abnormalities
60%
Bayley Scales of Infant Development
40%
Gestational Age
40%
Cerebral Hemorrhage
20%
Motor Performance
20%
Antibiotic Therapy
20%
Retinopathy of Prematurity
20%
Intubation
20%
Magnetic Resonance Imaging of Brain
20%
Language Ability
20%
Lung Dysplasia
20%
White Matter Injury
20%
Leukomalacia
20%
Benzodiazepine
20%
Treatment Group
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neuroprotection
100%
Erythropoietin
100%
Placebo
60%
Brain Injury
60%
Benzodiazepine
20%
Retrolental Fibroplasia
20%
Lung Dysplasia
20%
Brain Hemorrhage
20%
Intubation
20%
White Matter Injury
20%
Leukomalacia
20%
Treatment Group
20%